Dr. Minah Kim Wins VELOCITY Cancer Research Award

Herbert Irving Comprehensive Cancer Center Leadership just announced that Mina Kim, PhD, assistant professor of pathology and cell biology at Columbia University Irving Medical Center, has been selected as one of this year’s Velocity Fellows for her research project entitled “Targeting Vascular Abnormalities to Overcome Immune Checkpoint Inhibitor Resistance in Metastatic Melanoma”. 

Dr. Kim is studying mechanisms by which vascular abnormalities lead to therapeutic resistance to immune checkpoint inhibitor in patients with melanoma and drug combinations that could reverse resistance. This information will also help find potential vascular biomarker to predict patient responses to therapy. 

To learn more about the award, read the full announcement at HICCC News.